Answers are grounded in this paper and cite their sources.
PCR amplification, either conventional, or as site directed mutagenesis using primers with mismatched 3'-ends, followed by restriction endonuclease digestion, provides rapid, non-isotope assays of known mutations in the human phenylalanine hydroxylase gene. Such assays were shown to have the potential to detect all of the 18 presently reported phenylketonuria mutations. The practical applicability of this approach was demonstrated for eight mutations in Norwegian phenylketonuria patients, among them the most common ones.
No takes yet. Share an insight, caveat, or question.
Eiken et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: